Vaginal agenesis
Vaginal agenesis is a medical condition in which the vagina is underdeveloped or absent. It is a type of Müllerian agenesis, which refers to the failure of the Müllerian ducts to develop properly during fetal development. This condition is also known as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome when it occurs in combination with other abnormalities of the reproductive system.
Causes[edit]
Vaginal agenesis is a congenital condition, meaning it is present from birth. It is caused by the failure of the Müllerian ducts to develop properly during the early stages of fetal development. The exact cause of this failure is not known, but it is thought to be due to a combination of genetic and environmental factors.
Symptoms[edit]
The primary symptom of vaginal agenesis is the absence of menstruation (amenorrhea) despite normal development of secondary sexual characteristics such as breast development and pubic hair growth. Other symptoms may include recurrent urinary tract infections, pelvic pain, and difficulty with sexual intercourse.
Diagnosis[edit]
Diagnosis of vaginal agenesis is usually made during adolescence when menstruation fails to occur. A physical examination may reveal a shortened or absent vagina. Imaging tests such as ultrasound, MRI, or CT scan may be used to confirm the diagnosis and to check for other abnormalities of the reproductive system.
Treatment[edit]
Treatment for vaginal agenesis is aimed at creating a functional vagina for sexual intercourse and for psychological well-being. This may involve surgical procedures to create a neovagina, or non-surgical methods such as vaginal dilators. Psychological counseling may also be beneficial.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
